Corticotropin releasing factor (CRF) may regulate endocrine, autonomic, and behavioral responses to stress. Evidence indicates that CRF-like immunoreactivity (CRF-LI) is widely distributed throughout the CNS. In this study, the distribution of CRF-LI was determined in 36 rat brain regions by combined radioimmunoassay-micropunch dissection techniques and the effect of stress on CRF-LI was investigated, using a chronic stress model that induces endocrine changes in rats similar to those seen in depressed humans.
peptide, and shown to stimulate ACTH and p-endorphin secretion from the anterior pituitary (Rivier et al., 1982a) .
The importance of CRF in the response to stress is supported by the observation that systemic administration of a CRF antiserum significantly reduced plasma ACTH levels in ether-stressed rats (Rivier et al., 1982b) . Thus, as predicted, CRF appears to play an essential role in the pituitary-adrenal stress response. However, recent evidence suggests that CRF may also have extra-hypophysiotropic functions. Intracerebroventricular injection of CRF elicits behavioral activation of rats (B&ton et al., 1982; Sutton et al., 1982) , regulates activity of the sympathoadrenomedullary system Fisher et al., 1982) inhibits food consumption (Levine et al., 1983) and sexual behavior (Sirinathsinghji et al., 1983) and excites neurons in specific CNS loci, including the locus coeruleus (Ehlers et al., 1983; Valentino et al., 1983) . Many of these effects of centrally administered exogenous CRF are reminiscent of the signs and symptoms of depression in humans (Baldessarini, 1983) . Furthermore, radioimmunoassay Moldow and Fischman, 1982; Palkovits et al., 1985) and immunohistochemical (Cummings et al., 1983; Sawchenko and Swanson, 1985; Swanson et al., 1983 ) studies have demonstrated that CRF-like immunoreactivity exhibits a widespread and uneven distribution throughout the mammalian brain. These findings, taken together, raise the possibility that CRF might regulate the stress response within the CNS as well as through peripheral mechanisms.
Central 'effects of CRF are also of interest because of the increased activity of the hypothalamic-pituitary-adrenal (HPA) axis in many patients with depression, as evidenced by nonsuppression of plasma cortisol after administration of the synthetic glucocorticoid dexamethasone (Carroll et al., 1976) . Recently we have demonstrated that many depressed patients do, in fact, have elevated CSF concentrations of CRF-like immunoreactivity (CRF-LI) (Nemeroff et al., 1984) , suggesting that hyperactivity of CRF-containing neurons may be associated with, or even contribute to, the pathophysiology of depression. Furthermore, neurotransmitters such as norepinephrine, acetylcholine, and serotonin seem to be involved not only in depression (Weiss et al., 198 l) , but also in the regulation of CRF release from the hypothalamus during stress.
The purpose of this study was to characterize the distribution of CRF in the CNS of the rat and to determine whether acute or chronic stress alters the concentration of CRF in discrete brain nuclei. The development of a specific radioimmunoassay for CRF (Vale et al., 1983b) enabled us to determine the concentration of this peptide in various brain nuclei microdissected by the punch technique of Palkovits (1973) . We mapped changes in the concentration of CRF in 36 different rat brain regions following acute stress or a chronic stress protocol designed to maximize the unpredictable nature of the stressors (Katz et al., Ether stress for 45-60 set 8
Cold swim for 5 min at 0°C; isolation housing for 24 hr 9
Modified tail-pinch; 36 hr of increased housing density (10 animals/cage) 10
Ether stress for 45-60 set; 24 hr of isolation housing 11
Cold immobilization for 30 min at 4°C 12-13
Increased housing density for 48 hr (10 animals/cage) 14
Killed by decapitation 1981). We chose this later protocol in order to prevent the animals from developing tolerance to the stress, as they might have if the same stressor were repeated at regular intervals. In addition, this chronic stress model has been shown to induce endocrine changes in rats similar to those seen in humans with depression (Katz, 1982; Katz et al., 198 1) .
Materials and Methods

Animals
Thirty adult male Sprague-Dawley rats (Charles River Laboratories), weighing 150-250 gm at the start of the experiment, were housed 2 per cage, with food and water available ad libitum in an environmentally controlled animal facilitv (12 hr/12 hr liaht/dark cvcles with liehts on at 0700).
Stress procedures
Ten control rats and 10 rats assigned to the acute stress group were handled daily for 13 consecutive days in order to accustom them to the presence of humans and to minimize the effects of nonspecific stress. The acute stress group was subjected to acute immobilization stress, being restrained and placed supine in a 4°C cold room for 3 hr (from 1000 to 1300), as previously described (Nemeroff et al., 1982) . Rats in the control and acute stress groups were killed by decapitation, care being taken to first transport them in a nonstressful manner, as previously described (Uphouse et al., 1982) . At death, trunk blood was collected, centrifuged at 1500 rpm at 4°C for 15 min, and plasma was separated and frozen at -70°C for subsequent assay of corticosterone and ACTH. After decapitation, the brains and pituitaries were rapidly removed, frozen on dry ice, and stored at -70°C. Adrenal glands were also removed and their wet weights recorded.
In a modification of a previously described chronic stress regimen (Katz et al., 1981) , a third group of 10 rats was subjected to a 13 d course of unpredictable stressors. Various stressors were administered in order to maximize the unpredictability of both the type of stress and its timing. The details of the chronic stress paradigm are presented in Table 1 . On day 14 these rats were also killed; their brains, pituitaries, trunk blood, and adrenals were obtained as previously described.
Microdissection and sample preparation of brain regions
The microdissection of brain slices has been described in detail elsewhere (Palkovits and Brownstein, 1983) . In brief, brains were frozen ventral side up on dry ice and sliced into 300~pm-thick coronal sections in a cryostat at -10°C. With the exception of raphe nuclei, nuclei were removed bilaterally, using thin-walled stainless steel tubing (internal diameters: 0.57, 0.75, 0.91, and 1.15 mm). Samples were blown into polypropylene microcentrifuge tubes, placed on dry ice, and stored at -80°C until assayed.
Micropunched samples were homogenized by ultrasonic disruption in 500 ~1 1 N HCl. Following centrifugation at 10,000 rpm at 4°C for 15 min in a microcentrifuge, duplicate 200 ~1 aliquots were removed, lyophilized in 10 x 75 mm borosilicate glass tubes, and stored at -80°C until assayed. Pellets were lyophilized, stabilized in 300 ~1 1 N NaOH, and assayed for protein content by the method of Lowry et al. (195 1) .
CRF radioimmunoassay
The concentration of CRF-LI in the individual brain nuclei was measured in duplicate by modification of a previously described specific radioimmunoassay (RIA) for CRF (Vale et al., 1983b) , using an antiserum (oC30) raised in rabbits against ovine CRF. In brief, the lyophilized samoles were reconstituted in 200 ul RIA buffer (SPEAB buffer: 100 mM NaCl, 50 mM Na,HPO,, 25 rn; EDTA, O.l%'sodium azide, 0.1% BSA/O. 1% Triton X-100, pH 7.3) and incubated at 4°C for 18 hr with 100 pl oC30 antibody at a dilution of 1:35,000. Then 50 pl of the radiolabeled CRF trace, 1251-Tyro-rat/human CRF (20,000 cpm), prepared with chloramine-T and purified by HPLC, exactly as described by , was added. After an additional 6 hr at 4°C goat anti-rabbit serum (second antibody; Amel Products, NY) was added to precipitate the bound CRF (Nemeroff et al., 1984) .
CRF concentrations of all the brain regions were assayed in a single RIA. The sensitivity of the assay was 2.5 pg/tube and the intra-assay coefficient of variation was 9%. The CRF antibody does not detect any other known peptides, including sauvagine and urotensin I, and does not cross-react with vasouressin. ACTH, or angiotensin II (Gibbs and Vale, 1982) . CRF immunoreactivity in brain extracts subjected to HPLC has been shown to cochromatograph with synthetic CRF,,, (M. A. Smith et al., unpublished observations).
ACTH radioimmunoassay
Plasma ACTH concentrations were determined by a sensitive and specific RIA (Gutkowska et al., 1982; Orth, 1978) , using an antiserum raised in rabbits against thyroglobin-conjugated ACTH,,_,, that gives optimal binding at a final dilution of 1:600,000. The assay typically has a sensitivity of 1 pg/ml in plasma, and of the material bound by this antiserum in plasma, 95% is authentic ACTH (K. R. Krishnan and J. M. Ritchie, unpublished observations). All plasma samples were extracted prior to assay, using C-18 Sep-pak cartridges (Waters Associates, Milford. MA), to minimize nonsvecific binding effects from undiluted plasma.'The frozen pituitaries were prepared bfsonic disruption in 500 ~1 1 N HCl, followed by centrifugation (5000 rpm x 15 min at 0°C). The supematant was then extracted using C-18 Sep-pak cartridges, lyophilized, and reconstituted in ACTH RIA buffer (0.055 M Na,PO,, 0.02% sodium azide, 1.25% normal rabbit serum, 0.02% poly+lysine, 0.05% Triton X-100, pH 7.4) for assay at an antibody dilution of 1: 4000. Data were analyzed by the Student-Newman-Keuls multiple range test following 1 -way ANOVA, Cochran's C test, and the Bartlett Box F test for homogeneity of variance. Seven to ten determinations were obtained for each brain region. * Significantly different from controls but not from one another, p < 0.01. ** Significantly different from other 2 groups, p i 0.005. *** Significantly different from controls but not from chronic stress group, p < 0.0 1. **** Significantly different from other 2 groups, p < 0.00 1.
Corticosterone assay
Plasma corticosterone concentrations were determined using a modification of Murphy's competitive protein-binding radioassay, with a sensitivity of 0.3 &dl, as previously described (Murphy, 1967; Ritchie et al., 1985) . Sample radioactivity was measured using a Packard 460 liquid scintillation counter.
Statistical analysis
All data are presented as means + SEM. Results for adrenal weight, plasma ACTH, and corticosterone concentrations, as well as for pituitary ACTH content, were analyzed by a l-way analysis of variance (ANOVA) followed by Scheffe's test for multiple group comparisons. The effects of stress on CRF-LI concentrations in microdissected rat brain regions were analyzed by the Student-Newman-Keuls multiplerange test, following a one-way ANOVA and Cochran's C test. The Bartlett Box F test for analysis of homogeneity of variance was also employed.
Where necessary, data were subjected to logarithmic transformation to correct for heterogeneity of variance (Remington and Schork, 1970) .
Results
ACTH and corticosterone
As is shown in Table 2 , acute stress produced a significant rise in plasma ACTH and corticosterone concentrations. Adrenal weight was unaffected by exposure to acute stress. Following chronic stress, plasma corticosterone, but not ACTH, concentrations were increased. The rats exposed to chronic stress also exhibited a significant increase in adrenal weight.
Pituitary ACTH content was not affected either by acute or chronic stress. 
CRF distribution
In the control (nonstressed) rats, CRF-LI was detected in 35 of 36 brain regions, the highest concentrations being in the hypothalamus (Table 3) . Within this diencephalic brain region, the arcuate nucleus/median eminence (ME) contained the highest concentration, followed by the paraventricular (PVN) and periventricular nuclei. The medial preoptic (MPO), dorsomedial, lateral preoptic, anterior hypothalamic, and ventromedial nuclei contained similarly lower amounts.
Relatively low CRF-LI concentrations were found in the following neocortical regions: median prefrontal, pyriform, and entorhinal. In the cingulate cortex, CRF-LI was not reliably detected (Table 4) .
In the limbic system (Table 5) , the highest concentrations of CRF-LI were detected in the central and cortical nuclei of the amygdala and in the interstitial (bed) nucleus of the stria terminalis. The remaining amygdaloid nuclei (medial, basal, and lateral) also contained appreciable quantities of CRF-LI. The nucleus accumbens, medial and lateral septal nuclei, and the nucleus of the diagonal band, as well as the olfactory tubercles, substantia innominata, and the lateral habenula, contained moderate concentrations of CRF-LI. Relatively low concentrations of the peptide were detected in the dorsal and ventral hippocampus.
All midbrain regions contained substantial concentrations of CRF-LI (Table 6 ). The zona compacta of the substantia nigra contained the highest CRF-LI concentration of any of the midbrain regions studied, while somewhat lower concentrations were measured in the pars lateralis and zona reticularis of the substantia nigra. The periaqueductal gray and ventral tegmental area exhibited relatively high CRF-LI levels.
After the hypothalamus, the next highest CRF-LI concentrations were observed in the medial and dorsal raphe nuclei, regions known to be rich in serotonergic perikarya. The locus coeruleus (LC), comprised largely of adrenergic cell bodies, also contained a relatively high concentration of CRF-LI.
In the medulla, a substantial level of CRF-LI was detected in the dorsal vagal complex (DVC).
Efects of acute and chronic stress In most of the brain regions studied, CRF-LI concentrations were unchanged by acute or chronic stress. However, as is shown in Table 3 , acute stress markedly reduced CRF-LI in the arcuate nucleus/median eminence (down 52%) and the MPO nucleus (down 32%). In contrast to these results in the diencephalon, in the LC the concentration of CRF-LI was markedly increased (up 107%) by acute stress. Following chronic stress, no effect on the concentration of CRF-LI in the MPO area was noted, though increases in the periventricular nucleus, anterior hypothalamic nucleus, and LC were seen. Chronic stress also produced a reduction in CRF-LI in the DVC, while acute stress had no effect in this region (Fig. 1) .
It is of particular interest that neither acute nor chronic stress produced significant changes in the CRF-LI content of the PVN hypothalamic nucleus, an important site of CRF biosynthesis. In addition, an important limbic structure, the bed nucleus of the stria terminalis, exhibited an approximate 80% rise in CRF-LI concentration after acute and chronic stress, though this failed to achieve statistical significance, owing to higher than usual variance in both stress groups.
Discussion
The results of the present study with regard to the distribution of CRF-LI in nonstressed rats are similar but not identical to previous RIA studies. Fischman and Moldow (1982) measured CRF-LI concentrations in relatively large hypothalamic and extrahypothalamic rat brain regions obtained by the dissection method of Glowinski and Iversen (1966) , using an antibody raised in rabbits against synthetic ovine CRF and a tracer of Y-N-TyrO-ovine CRF. In a preliminary study, we also measured CRF-LI in rat brain regions dissected by a modification of the method of Glowinski and Iversen (1966) , and obtained similar results in the hypothalamus, amygdala, frontal cortex, and midbrain (M. A. Smith, unpublished observations). However, in 3 other brain regions (thalamus, hippocampus, and striatum), our results revealed substantially lower CRF-LI concentrations than those of Fischman and Moldow (1982) . Palkovits et al. (1985) quantitated CRF-LI (determined as ng CRF-LI/mg protein) in 70 microdissected rat brain nuclei using an antibody against synthetic rat CRF. The lowest detectable level of CRF-LI in their study was 300 pg/mg protein. They measured CRF-LI in 27 of the 36 regions examined in the present study. For 9 of these 27 common regions, including the frontal cortex, the hippocampus, and the nucleus accumbens, Palkovits et al. (1985) reported levels of CRF-LI below the limits of detection of their assay. In the present study, CRF-LI was detected in each of these regions in concentrations ranging from 22 to 190 pg/mg protein. In the remaining 18 regions in common, consistently lower (by 2-7-fold) concentrations of CRF-LI were detected in the present study. Only in the PVN nucleus were similar results attained. In the median eminence, for example, Palkovits et al. (1985) reported almost g-fold more CRF-LI than was detected in the present study in the arcuate nucleus/ median eminence complex. The discrepancies between the present findings and those of Palkovits et al. (1985) may partially be explained by a recent study by Skofitsch and Jacobowitz (1985) in which CRF-LI concentrations were determined by RIA in 50 discrete rat brain regions, using 4 antisera prepared from either synthetic rat/ human or ovine CRF. CRF-LI was identified in 26 of 50 regions by all 4 antisera, though dissimilar concentrations were frequently obtained for a given region using different antisera. In 18 of 50 regions, CRF-LI was detectable only with ovine CRF antisera. Similarly, Palkovits et al. (1985) , who employed an antibody to rat CRF, reported that CRF-LI was undetectable in 9 regions in which CRF-LI was detected in the present study, which used an antiserum to ovine CRF. Skofitsch and Jacobowitz (198 5) suggest that such discrepant results between RIAs using different antisera may indicate either that heterogeneous forms of the peptide are present or that the antisera are differentially affected by interfering substances from tissue extracts.
In addition, the inherent differences in micropunch surveys performed by different individuals are likely to have significantly contributed to the discrepancies between the present findings and those of Palkovits et al. (1985) . It has also been reported that RIAs with antisera such as oC30 detect rat CRF very poorly when 1251-labeled oCRF is used as the tracer, but are quite sensitive to rat/human CRF when iZSI-labeled rat/human CRF is used, as in the present study (Vale et al., 1983a) . The greater sensitivity of the present assay may be due in part to the use of goat anti-rabbit serum instead of Pansorbin to precipitate the CRF antiserum. Finally, differences in extraction techniques may also have contributed to the discrepant findings.
The present RIA results are generally concordant with the findings of previous immunohistochemical studies, though, as discussed by Skofitsch and Jacobowitz (1985) many variables preclude a perfect correlation between the 2 techniques. Such studies have repeatedly demonstrated that the largest collection of CRF-containing cells and fibers in the rat brain is found in the parvocellular division of the PVN nucleus (Bloom et al., 1982; Merchenthaler, 1984; Merchenthaler et al., 1983; Olschowka et al., 1982; Swanson et al., 1983) . In addition, a characteristic extrahypothalamic distribution of CRF-containing cells and fibers in close association with limbic parts of the telencephalon and with brain stem centers believed to be involved in the regulation of autonomic responses has been described (Swanson et al., 1983) . CRF-positive neurons have been found in all regions of the neocortex and appear to be more numerous in the prefrontal, cingulate, and entorhinal areas (Merchenthaler, 1984; Swanson et al., 1983) .
In the basal telencephalon, a large collection of cells that stained for CRF has been described in the central nucleus of the amygdala, the bed nucleus of the stria terminalis, and the substantia innominata-all areas found to contain substantial concentrations of CRF-LI in the present study. In the diencephalon, apart from the paraventricular nucleus, the most numerous CRF-positive neurons were detected in the MPO and periventricular nuclei (Merchenthaler, 1984) . In addition, a large CRFpositive cell cluster has been localized to the preoptioseptal region and found to be continuous laterally with the bed nucleus of the stria terminalis, caudally with the periventricular nucleus, and rostrally with the septal area (Petrusz et al., 1985) . These observations are compatible with the present finding that the periventricular nucleus contains the second highest concentrations of CRF-LI in the hypothalamus after the PVN, and that the MPO area also contains an appreciable concentration of CRF-LI.
In the mesencephalon, the majority of CRF-positive neurons have been identified in the periaqueductal gray and ventral tegmental area, while scattered cells were reported in the dorsal raphe nucleus (Merchenthaler, 1984) . Among the midbrain/brain stem regions examined in this study, the high concentrations of CRF-LI were found in the raphe nuclei, ventral tegmental area, and the periaqueductal gray.
In the pons and medulla, the largest collections of CRF-immunopositive cells and fibers were detected in the LC, the parabrachial nuclei, the nucleus of the solitary tract, and the DVC (Merchenthaler, 1984; Swanson et al., 1983) . The RIA results in the present study are consistent with this distribution.
As expected, acute stress produced a rise in circulating corticosterone, accompanied by an increase in ACTH concentrations. By contrast, chronic exposure to unpredictable stressors resulted in a significant elevation of plasma corticosterone concentration, while plasma ACTH concentrations returned to baseline. These results are compatible with earlier work by Katz (1980 Katz ( , 1982 and Katz et al. (1981) , who used a similar model of unpredictable stress. In contrast to acute stress, chronic stress was associated with significant adrenal hypertrophy, a finding concordant with earlier work demonstrating that adrenal weight can be used as an index of chronic stress (Daniels-Severs et al., 1973) and that, together with the failure ofplasma corticosterone to return to baseline, indicates that the chronically stressed animals did not become tolerant to the regimen of unpredictable stressors.
It is interesting to note that, taken together, the effects of chronic, unpredictable stress on the HPA axis in rats are not dissimilar to those observed in severely depressed psychiatric patients. Gold et al. (1984) have reported that, compared to controls, depressed patients tended to have higher mean cortisol values, while ACTH levels remained normal. Gold et al. (1984) also described a decrease in the ratio of ACTH to cortisol values in depressed patients, which was interpreted as compatible with the hypertrophy of the adrenals induced by chronic hyperstimulation with ACTH.
Changes in CRF-LI concentrations were found in several hypothalamic and brain stem nuclei following acute and chronic stress. Remarkably, changes in response to chronic stress were very similar to those induced by acute stress (see Fig. 1 ). However, a regimen of chronic, unpredictable stressors, which has been shown to produce behavioral and neuroendocrine changes in rats similar to endogenous depression in humans, was designed to circumvent the usual adaptive mechanisms elicited by the intermittent exposure of an animal to a single type of stressor (Katz and Roth, 1979; Katz et al., 1981) . This being the case, the changes described in CRF-LI in rats exposed to a variety of stressors might differ significantly from those found in rats intermittently exposed to a single stressor. This could explain the similarity of effect of both acute and chronic stress in the present study.
In the hypothalamus, acute stress produced alterations in CRF-LI concentrations in only 2 regions, the arcuate nucleus/ME and the MPO nucleus. Consistent with the proposed role of CRF in the regulation of the release of ACTH and other pro-opiomelanocortin-derived peptides from the anterior pituitary, acute stress produced a 52% reduction in CRF-LI in the arcuate nucleus/ME. This was presumably due to the stress-enhanced release of CRF-LI from nerve terminals in the ME into the hypothalamo-hypophysial portal circulation to activate the pituitary-adrenal axis. Because chronic stress did not totally deplete CRF-LI from the arcuate nucleus/ME, it can reasonably be assumed that there was ongoing or increased synthesis and transport of CRF-LI to the ME.
It is of interest that acute stress caused no significant change in the concentration of CRF-LI in the PVN, where the majority of CRF-containing cell bodies that project to the ME are localized. This suggests the existence in the terminals of the ME of a readily releasable pool of CRF-LI, which is rapidly depleted when the animal is exposed to acute stress. The fact that, com-pared to the lack of effect of acute stress, only a trend towards a decrease in CRF-LI is seen in the PVN after chronic stress suggests that adaptive changes in the rate of synthesis, processing, and transport of the peptide in this cell-body-rich region may develop over a longer period of time and may not be acutely detectable.
The decrease in CRF-LI in the MPO with acute stress is also intriguing, especially in view of the recent description (Petrusz, 1985) of a CRF-positive cell cluster, possibly larger than any previously described, located in the preoptic-septal area and centered in the MPO and periventricular preoptic nucleus. Similarly, Swanson et al. (1983) found the most intensely stained CRF-containing fibers in the rat brain in the dorsal parts of the MPO and the adjacent MPO nucleus. A decrement in CRF-LI in this region after acute stress is consistent with previous findings that have implicated the preoptic-septal region in the stress response (Saavedra, 1982; Saavedra et al., 1979; Seggie et al., 1974) . One plausible hypothesis is based on the fact that fibers from this area are known to project to the median eminence (Lechan et al., 1982) . If a circuit from the MPO, in contrast to the PVN, were selectively activated in the response to acute stress, the decrease in CRF-LI in this region might be caused by synthesis uncompensated by rapid axonal transport of CRF-LI to the ME.
Changes in the levels of CRF-LI in hypothalamic nuclei were accompanied by changes in CRF-LI in brain stem nuclei that are rich in norepinephrine-containing cells and have been implicated in the stress response (Ganong, 1984; Palkovits et al., 1975) . Both acute and chronic stress have identical effects on the LC, where CRF-LI concentrations were doubled under both conditions. Chronic stress, in addition, produced a 30% decrease in CRF-LI in the DVC, which encompasses the nucleus of the solitary tract in which the A, catecholaminergic cell group is embedded (Kvetnansky et al., 1978) . The possibility that CRF might be involved in the regulation of the autonomic nervous system is suggested by the distribution of the peptide in the CNS. Swanson et al. (1983) reported that CRF-containing cells and fibers were closely associated with cell clusters in the basal forebrain, hypothalamus, pons, and medulla, which are believed to have an important role in the integration of autonomic responses. Special emphasis was given to the role of the nucleus of the solitary tract, which (1) receives a direct sensory input from the vagal and glossopharyngeal nerves; (2) gives rise to a widespread, noradrenergic projection to the parvocellular subdivision of the PVN and other basal forebrain nuclei; and (3) may be involved in the relay of sensory information to, and coordination of responses from, CRF-stained cell clusters in this region. In addition, intracerebroventricular administration of CRF elevates plasma epinephrine and norepinephrine and increases arterial pressure and heart rate (Brown and Fisher, 1985; Brown et al., 1982) . Our finding that chronic stress produces a decrease in CRF-LI in the DVC is consistent with a proposed role for CRF in the regulation of the autonomic nervous system and its response to stress.
The LC, which consists almost entirely of noradrenergic neurons and projects widely throughout the neuraxis, including the parvocellular subdivision of the PVN , has also been repeatedly implicated in the stress response and arousal functions (Glavin, 1985; Korf et al., 1973; Thierry et al., 1968; Weiss et al., 198 1) . CRF-positive fibers and cells have been detected in the LC (Swanson et al., 1983) , and Valentino et al. (1983) found that CRF increased the discharge rates of LC neurons. We found that both acute and chronic stress increased CRF-LI in the LC. Whether this increase was due to increased translation or to increased prohormone-to-final hormone posttranslational processing, to decreased release, or to decreased catabolism remains to be determined, at least in part, by future characterization of the immunoreactive forms involved and of mRNA levels. However, our findings in the LC do provide additional support for the proposed role of CRF in the central integration of the stress response.
Finally, the close anatomical association of CRF-positive cells and fibers with adrenergic cells and processes has drawn frequent comment (Merchenthaler, 1984) and there have been speculations regarding functional relationships. Such speculations are buttressed by the finding that CRF can alter firing rates of LC noradrenergic neurons (Valentino et al., 1983) . It has also been established by dual staining procedures that CRF-positive neurons are distinct from those containing serotonin and dopamine beta hydroxylase (Merchenthaler et al., 1983) . The present findings are generally supportive of a functional relationship between the CRF system and the noradrenergic system in particular, although elucidation of the details of this relationship will require further work.
